NIH-funded research R01 grant

Helping people with head and neck cancer start post-surgery radiation on time

Official title: A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer

Funded at Medical University of South Carolina · NIH-11143127 · Data updated 2026-11-12

This project uses a patient navigation program to help people with head and neck cancer begin their recommended post-surgery radiation within six weeks of surgery.

More Head and Neck Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMedical University of South Carolina
NIH-funded
Lab location1 site (Charleston, United States)
Project startAugust 1, 2023
Project endJuly 31, 2028
Funding year2025
Award (this year)$690,864
NIH project number5R01CA282165-03
Project IDNIH-11143127 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are patients with head and neck cancer who have had surgery and are recommended to start postoperative radiation therapy.

Less likely to help

Patients who did not have surgery, do not need adjuvant radiation, or receive care outside the participating cancer centers would not be eligible or likely to benefit from enrolling.

What this research studies

You would be part of one of four cancer centers taking turns starting a navigation program that coordinates care after surgery. The program, called ENDURE, uses navigators and changes team workflows to overcome patient-, team-, and system-level barriers to timely postoperative radiation. Researchers will enroll about 484 patients across the sites and compare timing of radiation before and after each site adopts the program using a stepped-wedge design. The team will also study how the program works and how it can be implemented in different hospitals.

Why it matters

Potential benefit: If successful, this approach could reduce delays to starting postoperative radiation and help improve survival and outcomes for people with head and neck cancer.

How similar studies have gone: Earlier single-arm and pilot randomized work of ENDURE showed feasibility, acceptability, and preliminary improvement in timely radiation, but a larger trial is needed to confirm results.

Where this research is happening

  • Medical University of South Carolina
    Charleston, United States
    Active

Researchers

  • Principal investigator: Graboyes, Evan Michael — Medical University of South Carolina
  • Study coordinator: Graboyes, Evan Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.